http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012346195-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
filingDate 2012-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c7a16f619968af7c285c6eadc4e01e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5b0dec2aef32c68121d2d810e193acd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_556748843d26b1f6693353a0f9e8d7a5
publicationDate 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2012346195-A1
titleOfInvention Pharmaceutical compositions comprising 7-(1H-Imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for retinal neuroprotection
abstract The present invention relates to a method for retinal neuroprotection or for treating retinal diseases, in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 7-(1H-Imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline, its enantiomers or pharmaceutically acceptable salts thereof.
priorityDate 2011-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414161244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426408748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410749991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414354569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70660633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424970816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414481958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16663236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16654981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9899234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414628990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821

Total number of triples: 52.